Dimensional Fund Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Dimensional Fund Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$129K	Hold	82,204	–	–	﹤0.01%	3304
2022 Q2	$165K	Buy	+82,204	New	+$142K	﹤0.01%	3271
2019 Q4	–	Sell	-36,894	Closed	-$79K	–	3415
2019 Q3	$79K	Hold	36,894	–	–	﹤0.01%	3359
2019 Q2	$99K	Hold	36,894	–	–	﹤0.01%	3393
2019 Q1	$175K	Hold	36,894	–	–	﹤0.01%	3327
2018 Q4	$89K	Hold	36,894	–	–	﹤0.01%	3365
2018 Q3	$162K	Hold	36,894	–	–	﹤0.01%	3326
2018 Q2	$266K	Hold	36,894	–	–	﹤0.01%	3208
2018 Q1	$190K	Hold	36,894	–	–	﹤0.01%	3236
2017 Q4	$140K	Hold	36,894	–	–	﹤0.01%	3256
2017 Q3	$63K	Sell	36,894 -14,995	-29%	-$27.5K	﹤0.01%	3298
2017 Q2	$104K	Buy	51,889 +41,683	+408%	+$81.3K	﹤0.01%	3250
2017 Q1	$40K	Sell	10,206 -5,809	-36%	-$29.1K	﹤0.01%	3284
2016 Q4	$78K	Sell	16,015 -10,035	-39%	-$60.3K	﹤0.01%	3258
2016 Q3	$202K	Hold	26,050	–	–	﹤0.01%	3180
2016 Q2	$146K	Hold	26,050	–	–	﹤0.01%	3206
2016 Q1	$140K	Buy	+26,050	New	+$151K	﹤0.01%	3215

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Dimensional Fund Advisors's SRNE Position: Q3 2022 in Review

Dimensional Fund Advisors held its Sorrento Therapeutics, Inc. (SRNE) position steady in Q3 2022 at 82,204 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #3304.

Dimensional Fund Advisors first reported a position in SRNE in Q1 2016 and has held it in 17 quarters since. The position peaked at $266K in Q2 2018. 233 funds tracked by Wall St. Rank hold SRNE as of Q3 2022.

Dimensional Fund Advisors held 82,204 shares of Sorrento Therapeutics, Inc. worth $129K as of Q3 2022.
Dimensional Fund Advisors left its Sorrento Therapeutics, Inc. share count unchanged in Q3 2022.
Sorrento Therapeutics, Inc. made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2022, its #3304 holding.
Dimensional Fund Advisors first reported a position in Sorrento Therapeutics, Inc. in Q1 2016 and has held it in 17 quarters since.
Dimensional Fund Advisors's Sorrento Therapeutics, Inc. position peaked at $266K in Q2 2018.
233 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.